Stock Analysts’ Price Target Changes for November 15th (CABA, CTRA, DG, DIS, GLOB, KYTX, MDT, NEXN, TPR)

Stock Analysts’ price target changes for Friday, November 15th:

Cabaletta Bio (NASDAQ:CABA) had its price target trimmed by Wells Fargo & Company from $20.00 to $12.00. The firm currently has an overweight rating on the stock.

Coterra Energy (NYSE:CTRA) had its price target increased by Wells Fargo & Company from $32.00 to $35.00. They currently have an overweight rating on the stock.

Dollar General (NYSE:DG) had its target price lowered by Evercore ISI from $101.00 to $97.00. They currently have a hold rating on the stock.

Dollar General (NYSE:DG) had its price target cut by HSBC Holdings plc from $100.00 to $88.00. They currently have a hold rating on the stock.

Dollar General (NYSE:DG) had its target price lowered by Bernstein Bank from $98.00 to $94.00.

Walt Disney (NYSE:DIS) had its target price boosted by Needham & Company LLC from $110.00 to $130.00. Needham & Company LLC currently has a buy rating on the stock.

Globant (NYSE:GLOB) had its target price increased by Needham & Company LLC from $245.00 to $265.00. They currently have a buy rating on the stock.

Kyverna Therapeutics (NASDAQ:KYTX) had its target price lowered by Wells Fargo & Company from $44.00 to $24.00. The firm currently has an overweight rating on the stock.

Medtronic (NYSE:MDT) had its target price raised by Robert W. Baird from $90.00 to $96.00.

Medtronic (NYSE:MDT) had its price target trimmed by JPMorgan Chase & Co. from $99.00 to $96.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Nexxen International (NASDAQ:NEXN) had its price target increased by Needham & Company LLC from $8.50 to $9.50. The firm currently has a buy rating on the stock.

Tapestry (NYSE:TPR) had its target price boosted by Wells Fargo & Company from $65.00 to $75.00. Wells Fargo & Company currently has an overweight rating on the stock.